Vortex Pharma Solution

Expert operational and management solutions for drugs, diagnostic agents, and medical devices development projects. Vortex Pharma Solution provides in-depth clinical operations expertise covering trial life cycle end-to-end process. Using a holistic system, we ensure that your clinical trial is designed, setup, conducted, and reported with a risk-based approach, reasonable costs and the shortest possible timelines. We offer fit-for-purpose solutions to meet your specific needs and get your trial executed as planned. Therapeutic areas - Rare and ultra-rase diseases (orphan drug designation) - Endocrinology/metabolic diseases (diabetes, obesity, achondroplasia, growth hormone deficiency, hypoparathyroidism, thyroid-related diseases) - Hepatology (focal liver lesions, non-alcoholic steatohepatitis [NASH]) - Nephrology (chronic kidney disease [CKD]) - Neurology (Alzheimer’s disease) - Gastroenterology (Crohn’s disease) - Rheumatology (Osteoarthritis, Rheumatoid Arthritis) - Haematology (haemophilia, trauma, extensive surgery, intracerebral haemorrhage) - Cardiovascular (CV outcomes, arterial hypertension) - Oncology (breast cancer) - Dermatology (hyperhidrosis) Trial population - Paediatrics - Elderly - Adults Phases I to IV, RWE studies, post-authorization safety studies, interventional and observational studies